Abstract:OBJECTIVES: Cell-free DNA based non-invasive prenatal testing (NIPT) has been shown with closeto-diagnosis sensitivity and specificity in detecting fetal T21, T18, and T13. Future development of this technology focuses on detection of other chromosomal aneuploidies, and more importantly chromosome copy number variants (CNVs) and single-gene mutations. Validation studies were carried out to demonstrate the feasibility of detecting CNVs and single-gene disease by exploiting the cell-free DNA testing strategy and existing NIPT platforms. METHOD: For testing CNVs, 35 plasma samples with known fetal CNVs (>10 Mb in size) were recruited, together with 1077 plasma samples with normal fetal karyotypes as the control. The samples were blindly tested using the routine NIPT testing pipelines adopted at the clinical laboratories of BGI, and analyzed with the proprietary FCAPS protocol. Results were compared to the karyotyping results to calculate the sensitivity and specificity of the NIPT test. For testing single-gene disease, we developed a unique haplotype-assisted approach which was validated in a Maple Syrup Urine Disease (MSUD) case. In a trio family (father, mother in early pregnancy, and proband), targeted sequencing (180X) of the known genes causing MSUD was used to identify the disease causative mutations in the proband child and parents. At 13 gestational weeks, maternal plasma DNA and genomic DNA of the trio family were tested with a customized array at the sequencing depth of 40X and 20X respectively to retrieve the SNPs information for the purpose of parental haplotypes deduction. Linkage analysis and Hidden Markov Model were then used to construct the fetal genotype and haplotype flanking the MSUD mutation region. RESULTS: For CNV detection, with on average 4–5 M reads per sample and the existing NIPT platforms, we were able to use the FCAPS analytic protocol to identify 32 positive samples in total of 35, and generated 6 false positive cases, leading to overall sensitivity and specificity of 91.4% and 99.4% respectively. False positive rate and false negative rate of the test were 0.56% and 0.28% respectively. We also showed that with an increased sequencing depth, the detection power of the test can be further improved. In the MUSD case, deep targeted sequencing in the trio family identified that the proband child carries a missense mutation and a large deletion on BCKDHA gene, which were inherited from the mother and father respectively. With the SNP markers of the proband and parents, parental haplotype of chromosome 19 in 6148 loci were recovered. After fetal haplotype construction, the same alleles as that of the proband in the causative gene BCKDHA were inherited to the fetus, indicating that the fetus is a MSUD patient. This result was later confirmed by invasive diagnosis, and led to a well-informed decision after post-test counselling. CONCLUSIONS: We demonstrate the successful application of NIPT in detection of CNVs larger than 10 Mb without changing much to the current pipelines of aneuploidy detection. It has the potential to be integrated into the current NIPT test and offer extra benefits to the clinical service. The haplotype-assisted approach we developed requires minimum genetic information to accurately predict fetal condition. It has the clinical potential for noninvasive prenatal diagnosis of single gene disease for family with a proband child and seeks a second healthy child.

An Integrated Approach for Copy Number Variation Discovery in Parent-Offspring Trios.

Joint detection of copy number variations in parent-offspring trios.

Accuracy Of Cnv Detection From Gwas Data

Noninvasive detection of chromosomal CNV and single gene disease by massively parallel sequencing of cfDNA

VizCNV: An integrated platform for concurrent phased BAF and CNV analysis with trio genome sequencing data

Detection of Common Copy Number Variation with Application to Population Clustering from Next Generation Sequencing Data.

Genotype Calling and Haplotyping in Parent-Offspring Trios

Detecting Disease Variants in Case-Parent Trio Studies Using the Bioconductor Software Package Trio

Integrated Detection Of Copy Number Variation Based On The Assembly Of Ngs And 3gs Data

CNV-P: a machine-learning framework for predicting high confident copy number variations

A Bayesian framework for de novo mutation calling in parents-offspring trios

SeqCNV: a Novel Method for Identification of Copy Number Variations in Targeted Next-Generation Sequencing Data

CNVcaller: Highly Efficient and Widely Applicable Software for Detecting Copy Number Variations in Large Populations.

CNV-TV: A Robust Method to Discover Copy Number Variation from Short Sequencing Reads

A Single Cell Level Based Method For Copy Number Variation Analysis By Low Coverage Massively Parallel Sequencing

An evaluation of copy number variation detection tools from whole-exome sequencing data.

A Cluster-Based Approach for the Discovery of Copy Number Variations from Next-Generation Sequencing Data

Joint Detection of Germline and Somatic Copy Number Events in Matched Tumor-Normal Sample Pairs.

DL-CNV: A Deep Learning Method for Identifying Copy Number Variations Based on Next Generation Target Sequencing

SCCNV: A Software Tool for Identifying Copy Number Variation From Single-Cell Whole-Genome Sequencing

Efficient Mining of Variants from Trios for Ventricular Septal Defect Association Study